ExciMed Singapore Pte Ltd

19/03/2026

To all my friends and customers...

31/12/2025

To all valued customers and business partners... Happy New Year!!!

26/03/2025

Wishing everyone a Selamat Hari Raya 2025

24/12/2024

Merry Christmas to all our customers and users...

07/09/2024

Attending ESCRS 2024 in Barcelona

09/02/2024

Wishing Everyone a happy and blessed Lunar New Year!!!

21/11/2023

https://youtu.be/2SoKS0xm92o?si=a2b5RmjD4a43XoEB

The innovative Navilas® Laser System (OD-OS GmbH) is revolutionizing the treatment of retinal diseases with its excellent precision, speed, comfort and the p...

27/07/2022

After 3 Years, ExciMed Singapore will be attending the 40th Congress of the European Society of Cataract and Refractive Surgeons in Milan, Italy!!!

31/01/2022

ExciMed Singapore Wishes Everyone a Happy TIGER Lunar New Year!!

20/07/2021

Selamat Hari Raya Aidiladha to all our Muslim friends!

Take care & stay safe!

22/05/2021

New paper on

3-year results of (UCP) to treat glaucoma published by Jean-François , MD (France) and Florent , MD (France).

Journal of Glaucoma, 2021 May 1; 30(5):428-435
- 104 patients with primary or secondary glaucoma, only 44% with an history of glaucoma incisional surgery
- Single UCP procedure in 79% of eyes,
- IOP reduced from 27.6+/-8.9mmHg to 17.0+/-6.8mmHg at 3 years; few complications and no case of persistent hypotony or phthisis bulbi.
- 43% of IOP reduction in responding patients

“This is the first study reporting long-term results of UCP. It shows that UCP is an efficient and safe procedure to treat glaucoma and confirms the findings of comparable studies with shorter duration".

https://www.linkedin.com/posts/excimedgroup_3-year-study-on-efficacy-safety-of-ucp-activity-6801679649798807552-EVnP